B01-Notice of Intent to Sole Source.pdf
PDF 89 KB Posted
- Attached to
- Reagent Adapters Supplies, WRAIR Federal contract opportunity
- Solicitation number
- Not on record
- Issued by
- Defense Health Agency
About this file
This notice of intent to sole source outlines requirements for reagent adapters supplies for the Walter Reed Army Institute of Research's bacterial disease branch. The United States Army Medical Research Acquisition Activity intends to negotiate solely with Integrated DNA Technologies to provide consumables including a set of 384 TruSeq-compatible duplex full length Y adapters. These reagents and consumables are needed to sustain molecular sequencing research using existing government-owned Illumina whole genome sequencers, which are critical to the bacterial disease branch's mission to characterize multidrug-resistant organisms. Interested parties may submit capability information by January 8, 2024 to demonstrate ability to provide these products, however the government reserves sole discretion to not compete the procurement based on responses. If no responses are received, the sole source contract will be awarded to Integrated DNA Technologies.
View the file
Other files for this federal contract opportunity
| File | Type | Posted |
|---|---|---|
| B01-Notice of Intent to Sole Source 29 Jan 2024.pdf |
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Notice of Intent to Sole Source
Date: 29 January 2024
Contracting Office Address – US Army Medical Research Acquisition Activity (USAMRAA), 820 Chandler Street, Fort Detrick, MD 21702-5014
Subject: Notice of Intent to Sole Source – Reagent Adapters Supplies, Walter Reed Army Institute of Research (WRAIR)
Solicitation Number: HT942524R0035
The United States Army Medical Research Acquisition Activity (USAMRAA) intends to negotiate on a sole source basis IAW FAR 6.302-1 with vendor Integrated DNA Technologies
This requirement is to purchase the necessary consumables for the Illumina whole genome sequencers owned by the Bacterial Disease Branch’s (BDB), WRAIR. The consumables will include a set of 384 TruSeq-Compatiable Duplex full length Y adapters. The BDB utilizes the Illumina whole genome sequencers to analyze entire genomes as part of its effort to collect and characterize multidrug-resistant organisms to inform best clinical practices, influence policy, and enhance infection prevention and control efforts within the U.S. military health system. Currently, there are no other vendors that are able to provide the required consumables for the Illumina whole genome sequencers as the consumables are proprietary to the Original Equipment Manufacturer (OEM), Illumina, who is partnering with vendor Integrated DNA Technologies to manufacturer the consumables. Failure to award this contract to Integrated DNA Technologies would result in the inability to use the existing Government-owned Illumina whole genome sequencers, which are critical to BDB’s established mission.
Objectives
The contractor shall provide reagents and consumables to sustain molecular sequencing research for BDB’s existing whole genome sequencers. Integrated DNA Technologies produces custom manufactured DNA and RNA Oligonucleotides in accordance with GMP ISO 13485 grade adapter manufacturing practices for clinical research applications which meets BDB’s molecular sequencing performance requirements. This Indefinite Delivery /Indefinite Quantity (IDIQ) for In Vitro Diagnostic Reagent Adapters, will provide full lengthTruSeq™–Compatible Duplex Y Adapters 96 rxn (s); Single Rxn Plates (PCR) with Unique Dual Index (UDI) configuration and a formulation specification of 0.14nmol/7.5Um/18uL. T
THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTATIONS.
Responsible, interested parties may identify their interest by submitting capability information, in writing, by 2:00 p.m. est. 8 January 2024 to Mr. Nathaniel Reus at Nathaniel.a.reus.civ@health.mil.
Supporting evidence must be furnished in sufficient detail to demonstrate the firm’s ability to provide the stated capability.
Responses will be evaluated; however, a determination by the Government not to compete the proposed procurement based upon responses to this notice is solely within the discretion of the Government. If no responses are received, USAMRAA will proceed with the sole source contract.
mailto:Nathaniel.a.reus.civ@health.mil
File details come from the government source that posted it. Updated .